Mesenchymal stem cells are mobilized from the bone marrow during inflammation

Frontiers in Immunology

Volumn 4, Issue MAR, 2013, Pages

  Koning, Jasper J ^a   Kooij, Gijs ^a   de Vries, Helga E ^a   Nolte, Martijn A ^b   Mebius, Reina E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow and MSC; CD70; Experimental allergic encephalomyelitis; Inflammation and MSC; MSC and IFNg; MSC mobilization

Indexed keywords

CD70 ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MESENCHYMAL STEM CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; STEM CELL MOBILIZATION;

EID: 84883779024     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00049     Document Type: Article

References (43)

1. Adelmann, M., Wood, J., Benzel, I., Fiori, P., Lassmann, H., Matthieu, J. M., et al. (1995). The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 63, 17-27.
2. Arens, R., Tesselaar, K., Baars, P. A., van Schijndel, G. M., Hendriks, J., Pals, S. T., et al. (2001). Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 15, 801-812.
3. Avigdor, A., Goichberg, P., Shivtiel, S., Dar, A., Peled, A., Samira, S., et al. (2004). CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 103, 2981-2989.
4. Bruck, W., Kuhlmann, T., and Stadelmann, C. (2003). Remyelination in multiple sclerosis. J. Neurol. Sci. 206, 181-185.
5. Codarri, L., Gyulveszi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., et al. (2011). RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560-567.
6. da Silva, M. L., Chagastelles, P. C., and Nardi, N. B. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119, 2204-2213.
7. de Bruin, A. M., Buitenhuis, M., van der Sluijs, K. F., van Gisbergen, K. P., Boon, L., and Nolte, M. A. (2010). Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-gamma. Blood 116, 2559-2569.
8. Ding, L., Saunders, T. L., Enikolopov, G., and Morrison, S. J. (2012). Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457-462.
9. Di Rosa, F., and Pabst, R. (2005). The bone marrow: a nest for migratory memory T cells. Trends Immunol. 26, 360-366.
10. Eglitis, M. A., Dawson, D., Park, K. W., and Mouradian, M. M. (1999). Targeting of marrow-derived astrocytes to the ischemic brain. Neuroreport 10, 1289-1292.
11. Ewing, C., and Bernard, C. C. (1998). Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol. Cell Biol. 76, 47-54.
12. Fancy, S. P., Kotter, M. R., Harrington, E. P., Huang, J. K., Zhao, C., Rowitch, D. H., et al. (2010). Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp. Neurol. 225, 18-23.
13. Feuerer, M., Beckhove, P., Garbi, N., Mahnke, Y., Limmer, A., Hommel, M., et al. (2003). Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat. Med. 9, 1151-1157.
14. Friedenstein, A. J., Piatetzky-Shapiro, I. I., and Petrakova. K. V. (1966). Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16, 381-390.
15. Fry, T. J., and Mackall, C. L. (2005). The many faces of IL-7, from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174, 6571-6576.
16. Gerdoni, E., Gallo, B., Casazza, S., Musio, S., Bonanni, I., Pedemonte, E., et al. (2007). Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61, 219-227.
17. Hemmer, B., Archelos, J. J., and Hartung, H. P. (2002). New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3, 291-301.
18. Jones, S., Horwood, N., Cope, A., and Dazzi, F. (2007). The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J. Immunol. 179, 2824-2831.
19. Kassis, I., Grigoriadis, N., Gowda-Kurkalli, B., Mizrachi-Kol, R., Ben-Hur, T., Slavin, S., et al. (2008). Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch. Neurol. 65, 753-761.
20. Koning, J. J., and Mebius, R. E. (2011). Interdependence of stromal and immune cells for lymph node function. Trends Immunol. 33, 264-270.
21. Kooij, G., Backer, R., Koning, J. J., Reijerkerk, A., van, H. J., van der Pol, S. M., et al. (2009). P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS ONE 4:e8212. doi: 10.1371/journal.pone.0008212
22. Kopen, G. C., Prockop, D. J., and Phinney, D. G. (1999). Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. U.S.A. 96, 10711-10716.
23. Kuznetsov, S. A., Krebsbach, P. H., Satomura, K., Kerr, J., Riminucci, M., Benayahu, D., et al. (1997). Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12, 1335-1347.
24. Kuznetsov, S. A., Mankani, M. H., Gronthos, S., Satomura, K., Bianco, P., and Robey, P. G. (2001). Circulating skeletal stem cells. J. Cell Biol. 153, 1133-1140.
25. Lanza, C., Morando, S., Voci, A., Canesi, L., Principato, M. C., Serpero, L. D., et al. (2009). Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J. Neurochem. 110, 1674-1684.
26. Lassmann, H., Bruck, W., and Lucchinetti, C. (2001). Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 7, 115-121.
27. Matsuyama, W., Kubota, R., Hashiguchi, T., Momi, H., Kawabata, M., Nakagawa, M., et al. (2002). Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro. Immunology 106, 96-101.
28. Mendez-Ferrer, S., Michurina, T. V., Ferraro, F., Mazloom, A. R., Macarthur, B. D., Lira, S. A., et al. (2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829-834.
29. Nolte, M. A., Arens, R., van, O. R., van, O. M., Hooibrink, B., van Lier, R. A., et al. (2005). Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nat. Immunol. 6, 412-418.
30. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., and Weinshenker, B. G. (2000). Multiple sclerosis. N. Engl. J. Med. 343, 938-952.
31. Pitchford, S. C., Furze, R. C., Jones, C. P., Wengner, A. M., and Rankin, S. M. (2009). Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 4, 62-72.
32. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
33. Prockop, D. J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71-74.
34. Scolding, N., and Franklin, R. (1998). Axon loss in multiple sclerosis. Lancet 352, 340-341.
35. Segal, B. M. (2010). Th17 cells in autoimmune demyelinating disease. Semin. Immunopathol. 32, 71-77.
36. Sospedra, M., and Martin, R. (2005). Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683-747.
37. Steinman, L. (2001). Multiple sclerosis: a two-stage disease. Nat. Immunol. 2, 762-764.
38. Tokoyoda, K., Hauser, A. E., Nakayama, T., and Radbruch, A. (2010). Organization of immunological memory by bone marrow stroma. Nat. Rev. Immunol. 10, 193-200.
39. 4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity 30, 721-730.
40. Uccelli, A., Moretta, L., and Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726-736.
41. Wang, C. H., Cherng, W. J., Yang, N. I., Kuo, L. T., Hsu, C. M., Yeh, H. I., et al. (2008). Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler. Thromb. Vasc. Biol. 28, 54-60.
42. Zamvil, S. S., and Steinman, L. (1990). The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8, 579-621.
43. Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., et al. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106, 1755-1761.